Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy

NCT ID: NCT00223782

Last Updated: 2008-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-05-31

Study Completion Date

2006-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether individuals with diabetic peripheral neuropathy can learn to change the way they walk in order to reduce the pressures underneath the feet, which may lead to a reduced risk of foot ulceration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study suggests that teaching a new strategy is beneficial to decrease the forefoot peak plantar pressure in individuals who are susceptible to plantar ulcerations. It has not, however, been studied whether these changes would be maintained long-term or if they had any effect on the ulceration rate. Additionally, no analysis of the amount of visual feedback necessary to elicit the desired motor pattern was discussed. It has been suggested that proprioception plays an integral role in the use of feedback to develop error-detection mechanisms by integrating visual feedback and kinesthetic variables. In the diabetic peripheral neuropathy subject population, proprioception and kinesthesia may be compromised. This may have effects on the ability of this population to maintain changes in inappropriate movement patterns. A significant portion of patients continue to develop plantar ulcers even with prescriptive footwear compliance, so gait training to change inappropriate patterns which result in the high plantar pressures may be critical to prevent ulceration.

Comparisons: Two groups of subjects will receive gait training, one group will receive feedback of performance while the other will only receive training, and one control group. Comparisons will include whether plantar pressures are decreased in the training groups, and if those changes are maintained long-term.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Peripheral Neuropathy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Diabetes Peripheral Neuropathy Walking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type OTHER

Gait Training with Feedback

Intervention Type BEHAVIORAL

Gait Training with no feedback

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gait Training with Feedback

Intervention Type BEHAVIORAL

Gait Training with no feedback

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosis of diabetes for at least one year.
2. Diabetic peripheral neuropathy as defined by failure to sense the 5.07 (10g) monofilament test in one or more of the six sites tested (31;32)
3. Age 50-80 years old
4. Able to ambulate independently without assistive devices (e.g. walker or crutches) (8) for 30 feet.
5. No evidence of neurological (other than peripheral neuropathy) or orthopedic conditions

Exclusion Criteria

1. Other non-diabetic causes of neuropathy by history
2. Symptomatic peripheral vascular disease
3. Joint pain, swelling and/or limited of range of motion in the lower extremities that interfere with walking or exercise
4. Visual problems not correctable with glasses or contact lens
5. Passive range of motion limitations are described as:

1. Hip flexion \< 1000;
2. Hip extension \< 200;
3. Knee flexion \< 1250;
4. Knee extension \< 00 (unable to obtain full extension);
5. Ankle plantar flexion \< 250;
6. Ankle dorsiflexion \< 150
6. Other systemic or local diseases that could interfere with walking assessment
7. Severe systemic diseases other than diabetes or its complications, especially those interfering with exercise tolerance
8. Amputation in the lower extremities
9. Terminal illness
10. Severe obesity: BMI\>30 kg/m2 (33)
11. Severe foot deformities (e.g. flexion contracture of the toes, pes cavus, Charcot disease)
12. Mini-mental status of \<27 or diagnosis of dementia
13. History of alcohol or drug abuse
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

US Department of Veterans Affairs

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Veterans Affairs

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen Perell, PhD RKT

Role: PRINCIPAL_INVESTIGATOR

VA Greater Los Angeles Healthcare System, West LA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA Greater Los Angeles Healthcare System, West LA

West Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A3117R

Identifier Type: -

Identifier Source: org_study_id